| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Meng Yin | Q42714178 |
| P2093 | author name string | Richard L Ehman | |
| Jayant A Talwalkar | |||
| Patrick S Kamath | |||
| Jeff L Fidler | |||
| Schuyler O Sanderson | |||
| P2860 | cites work | Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study | Q24680285 |
| Magnetic resonance elastography by direct visualization of propagating acoustic strain waves | Q28290066 | ||
| Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
| Assessment of hepatic fibrosis with magnetic resonance elastography | Q30493170 | ||
| Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C | Q30499178 | ||
| Applications of magnetic resonance spectroscopy to chronic liver disease | Q30652115 | ||
| Assessment of diffusion-weighted MR imaging in liver fibrosis. | Q31083499 | ||
| Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review | Q33263463 | ||
| Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy | Q33866383 | ||
| Liver biopsy | Q33932981 | ||
| Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models | Q34410029 | ||
| Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. | Q34544284 | ||
| Selected Methods for Imaging Elastic Properties of Biological Tissues | Q35110676 | ||
| Inter-observer and intra-observer variability in hepatology | Q35201365 | ||
| An appraisal of the histopathological assessment of liver fibrosis | Q35760393 | ||
| Evaluation of liver fibrosis: a concise review | Q35794328 | ||
| Nonalcoholic fatty liver disease: a review of current understanding and future impact | Q35996525 | ||
| The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis | Q36066776 | ||
| In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. | Q36075759 | ||
| Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide | Q36135498 | ||
| Hepatic imaging: comparison of modalities | Q36228349 | ||
| Future directions in body magnetic resonance imaging | Q36325503 | ||
| Performance of serum marker panels for liver fibrosis in chronic hepatitis C. | Q36373907 | ||
| Reversal of hepatic fibrosis -- fact or fantasy? | Q36382260 | ||
| Diffusion-weighted imaging of the liver: technical challenges and prospects for the future | Q36423750 | ||
| Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging | Q36461222 | ||
| MR elastography of the liver: preliminary results | Q36545610 | ||
| Hepatic imaging in the 21st century | Q36628293 | ||
| MR contrast agents for liver imaging: what, when, how. | Q36652700 | ||
| Development and applications of in vivo clinical magnetic resonance spectroscopy | Q36846143 | ||
| An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. | Q39551580 | ||
| Projecting future complications of chronic hepatitis C in the United States | Q40594872 | ||
| In vivo hepatic magnetic resonance spectroscopy: clinical or research tool? | Q41191203 | ||
| Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings | Q43806739 | ||
| Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases | Q44324874 | ||
| Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide | Q44865317 | ||
| The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. | Q45021254 | ||
| Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers | Q46080794 | ||
| Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy | Q46434804 | ||
| Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability | Q46545985 | ||
| Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. | Q46953851 | ||
| Diffusion-weighted MR imaging of the liver of hepatitis C patients | Q47731508 | ||
| Magnetic resonance elastography: non-invasive mapping of tissue elasticity | Q48697731 | ||
| The burden of gastrointestinal and liver diseases, 2006. | Q50785635 | ||
| Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. | Q51023698 | ||
| Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. | Q51545030 | ||
| In vivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography. | Q51928911 | ||
| Tissue characterization using magnetic resonance elastography: preliminary results. | Q52890961 | ||
| Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. | Q52912744 | ||
| Cirrhosis: modified caudate-right lobe ratio. | Q52942476 | ||
| Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. | Q52947167 | ||
| Non-invasive detection of liver fibrosis: Is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? | Q52948689 | ||
| Non-invasive diagnosis of liver cirrhosis: magnetic resonance imaging presents special features. | Q53587537 | ||
| Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. | Q53711274 | ||
| In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver | Q57189334 | ||
| Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease | Q58622754 | ||
| New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis | Q59352932 | ||
| Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies | Q70032258 | ||
| An in vivo 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity | Q70730723 | ||
| MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: influence of liver dysfunction and parenchymal pathology | Q71188265 | ||
| Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience | Q73593544 | ||
| Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis | Q73655739 | ||
| Burden of liver disease in the United States: summary of a workshop | Q74367086 | ||
| Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function | Q77698878 | ||
| Functional hepatic imaging and disease recurrence after liver transplantation | Q79390848 | ||
| Shall we bury the sword? Imaging of hepatic fibrosis | Q79451123 | ||
| Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation | Q79846807 | ||
| Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis | Q81453163 | ||
| Can Doppler sonography grade the severity of hepatitis C-related liver disease? | Q81771767 | ||
| Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis | Q81877991 | ||
| Liver fibrosis: non-invasive assessment with MR elastography | Q82748251 | ||
| Science to Practice: Can MR imaging replace liver biopsy for the diagnosis of early fibrosis? | Q83206452 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 332-342 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications | |
| P478 | volume | 47 |
| Q27309869 | 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model |
| Q42263583 | A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal. |
| Q30476140 | Abdominal magnetic resonance elastography |
| Q30454078 | Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. |
| Q30478601 | Advanced MRI methods for assessment of chronic liver disease |
| Q34986092 | Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varices |
| Q30453975 | An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver |
| Q37669172 | Antifibrotic therapies--emerging biomarkers as treatment end points |
| Q40268874 | Application of Single Voxel 1H Magnetic Resonance Spectroscopy in Hepatic Benign and Malignant Lesions. |
| Q36156172 | Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update |
| Q53111952 | Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study. |
| Q37345958 | Assessing liver fibrosis. |
| Q36332475 | Assessment of biopsy-proven liver fibrosis by 2D-shear wave elastography: An individual patient data based meta-analysis |
| Q30474248 | Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging |
| Q37995326 | Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques |
| Q30357722 | Automated liver elasticity calculation for MR elastography |
| Q30433801 | Automated liver stiffness measurements with magnetic resonance elastography. |
| Q30398077 | Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers |
| Q30465168 | Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis |
| Q30401280 | Concurrent Visualization of Acoustic Radiation Force Displacement and Shear Wave Propagation with 7T MRI. |
| Q30473375 | Current status of novel antifibrotic therapies in patients with chronic liver disease |
| Q34318149 | Development and application of magnetic resonance elastography of the normal and pathological thyroid gland in vivo |
| Q79761734 | Diagnosis of liver fibrosis in 2008 |
| Q38286648 | Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value |
| Q30467234 | Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography |
| Q35775870 | Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography. |
| Q34073553 | Effects of microperfusion in hepatic diffusion weighted imaging. |
| Q36059493 | Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T. |
| Q39920327 | Evaluation of liver fibrosis with T1ρ MR imaging |
| Q37768335 | Evolving challenges in hepatic fibrosis |
| Q36357269 | Experimental evaluation of accelerated T1rho relaxation quantification in human liver using limited spin-lock times. |
| Q90376281 | Fluorescence spectroscopy as an efficient tool for staging the degree of liver fibrosis: an in vivo comparison with MRI |
| Q39276560 | Further exploration of MRI techniques for liver T1rho quantification |
| Q37609582 | Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis. |
| Q30395051 | Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations |
| Q37629675 | Hepatic inflammation and progressive liver fibrosis in chronic liver disease |
| Q37708229 | Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations |
| Q90091780 | Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels |
| Q41552555 | Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents |
| Q38509320 | Imaging patterns of fatty liver in pediatric patients |
| Q57651838 | Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy |
| Q26752471 | KASL clinical practice guidelines: management of hepatitis C |
| Q51836024 | KASL clinical practice guidelines: management of hepatitis C. |
| Q36365476 | Liver T1ρ MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence |
| Q30448132 | Liver elastography, comments on EFSUMB elastography guidelines 2013. |
| Q26780252 | Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. |
| Q35040294 | Liver lobe volumes and the ratios of liver lobe volumes to spleen volume on magnetic resonance imaging for staging liver fibrosis in a minipig model |
| Q30470829 | Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. |
| Q30403258 | MR Elastography of Liver Disease: State of the Art. |
| Q50441063 | MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide |
| Q84509799 | MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication |
| Q53697565 | MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. |
| Q37851078 | MR elastography monitoring of tissue-engineered constructs |
| Q37986054 | MR imaging in liver cirrhosis: classical and new approaches |
| Q37644144 | MR imaging of liver fibrosis: current state of the art. |
| Q38210190 | MRI of diffuse liver disease: characteristics of acute and chronic diseases |
| Q30403315 | Magnetic Resonance Elastography |
| Q39090541 | Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. |
| Q37509053 | Magnetic resonance elastography hardware design: a survey. |
| Q30368978 | Magnetic resonance elastography in a rabbit model of liver fibrosis: a 3-T longitudinal validation for clinical translation |
| Q30443567 | Magnetic resonance elastography noninvasively detects in vivo renal medullary fibrosis secondary to swine renal artery stenosis |
| Q43963538 | Magnetic resonance elastography of liver in healthy Asians: normal liver stiffness quantification and reproducibility assessment. |
| Q36095895 | Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability |
| Q33535981 | Magnetic resonance elastography: a general overview of its current and future applications in brain imaging |
| Q30474915 | Magnetic resonance elastography: a review |
| Q57066240 | Magnetic resonance elastography: basic principles, technique, and clinical applications in the liver |
| Q38268974 | Measurement of passive skeletal muscle mechanical properties in vivo: recent progress, clinical applications, and remaining challenges |
| Q29619336 | Mechanisms of hepatic fibrogenesis |
| Q36177218 | Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models |
| Q30386588 | Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model. |
| Q30354346 | New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. |
| Q33499918 | New techniques for the quantification of fibromyalgia and myofascial pain |
| Q30474738 | Non-invasive assessment of liver fibrosis in chronic hepatitis C. |
| Q26780258 | Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. |
| Q40707349 | Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. |
| Q42285158 | Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C. |
| Q30442641 | Non-invasive diagnosis of hepatitis B virus-related cirrhosis |
| Q37386095 | Non-invasive diagnosis of steatosis and fibrosis. |
| Q55429783 | Non-invasive in vivo Imaging Grading of Liver Fibrosis. |
| Q30877287 | Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data |
| Q24649618 | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management |
| Q30397191 | Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions |
| Q83258968 | Noninvasive assessment of liver fibrosis |
| Q84051868 | Noninvasive assessment of liver fibrosis |
| Q30432576 | Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future |
| Q38141711 | Noninvasive evaluation of NAFLD. |
| Q43007383 | Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis C. |
| Q30464087 | Noninvasive tools to assess hepatic fibrosis: ready for prime time? |
| Q38504279 | Pattern and profile of chronic liver disease in acute on chronic liver failure |
| Q37807779 | Pediatric nonalcoholic fatty liver disease: a comprehensive review. |
| Q37978790 | Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis |
| Q39724337 | Piezoelectric actuator design for MR elastography: implementation and vibration issues. |
| Q36067595 | Platelet count combined with right liver volume and spleen volume measured by magnetic resonance imaging for identifying cirrhosis and esophageal varices |
| Q30466193 | Portal hypertension correlates with splenic stiffness as measured with MR elastography |
| Q38975618 | Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic? |
| Q36868728 | Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score. |
| Q35110946 | Quantitative assessment of the presence and severity of cirrhosis in patients with hepatitis B using right liver lobe volume and spleen size measured at magnetic resonance imaging |
| Q37839093 | Recent advances in imaging hepatic fibrosis and steatosis |
| Q37204019 | Recent advances in the pathogenesis and diagnosis of liver fibrosis |
| Q38229320 | Recurrent HCV after liver transplantation-mechanisms, assessment and therapy |
| Q30476723 | Repeatability of magnetic resonance elastography for quantification of hepatic stiffness |
| Q38175465 | Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis |
| Q38042443 | Review article: the reversibility of cirrhosis |
| Q30448711 | Review of MR elastography applications and recent developments |
| Q90609747 | Rheological determinants for simultaneous staging of hepatic fibrosis and inflammation in patients with chronic liver disease |
| Q37716891 | Role of magnetic resonance elastography in compensated and decompensated liver disease |
| Q28072862 | Role of spleen elastography in patients with chronic liver diseases |
| Q30406463 | Spatially-resolved hydraulic conductivity estimation via poroelastic magnetic resonance elastography |
| Q43925619 | Spleen magnetic resonance diffusion-weighted imaging for quantitative staging hepatic fibrosis in miniature pigs: An initial study |
| Q47258656 | Spleen size measured on enhanced MRI for quantitatively staging liver fibrosis in minipigs |
| Q30403449 | Stable Automated Segmentation of Liver MR Elastography Images for Clinical Stiffness Measurement. |
| Q28085479 | State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives |
| Q30383680 | T2 relaxation time is related to liver fibrosis severity. |
| Q37587875 | Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. |
| Q85205306 | To B(iopsy) or Not to B(iopsy) … |
| Q34417027 | Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study |
| Q34129273 | Viscoelasticity-based Staging of Hepatic Fibrosis with Multifrequency MR Elastography |
Search more.